Span Divergent Ltd

NSE: SPANDIAQ · BSE: 524727 · Pharmaceuticals & Biotechnology · 26 announcements

Share price: ₹27.10
Market cap: ₹19.68 Cr
Revenue (annual): ₹17.22 Cr
Net profit (annual): ₹-2.50 Cr
P/E (TTM): -5.4×Sector 43.8×
Promoter holding: 48.13%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Legal & Regulatory 4 Financial Results 4 Board Meeting Date 3 Annual General Meeting 3 Merger & Restructuring 1 Debt & Borrowing 1 Capital Structure Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

5 Nov 2026 19:27 IST BSE

Financial Results

Span Divergent Q2 FY27 Results: Net Loss of ₹0.8 Cr, Loss Widens

Span Divergent Ltd reported revenue from operations of ₹5.4 Cr (-28.9% YoY) and a net loss of ₹0.8 Cr for Q2 FY27.

Key figure: Net loss ₹0.8 Cr

Open full results → Read the filing ↗

11 Aug 2026 16:34 IST BSE

Financial Results

Span Divergent Q1 FY27 Results: Net Loss of ₹1.2 Cr, Loss Widens

Span Divergent Ltd reported revenue from operations of ₹1 Cr (-9.1% YoY) and a net loss of ₹1.2 Cr for Q1 FY27.

Key figure: Net loss ₹1.2 Cr

Open full results → Read the filing ↗

30 May 2026 18:06 IST BSE

Financial Results

Span Divergent Q4 FY26 Results: Net Loss of ₹1.1 Cr, Loss Widens

Span Divergent Ltd reported revenue from operations of ₹4.6 Cr (+820.0% YoY) and a net loss of ₹1.1 Cr for Q4 FY26.

Key figure: Net loss ₹1.1 Cr

Open full results → Read the filing ↗

30 May 2026 18:05 IST BSE

Financial Results

Span Divergent Financial Results

Span Divergent Limited approved its FY26 audited financial results and skipped recommending a dividend. The board also appointed Christie & Co. as internal auditors for FY27.

Open announcement → Read the filing ↗